D Dimer: A routine assay with unique challenges @Labroots
D Dimer: A routine assay with unique challenges  @Labroots
Uploaded November 2026 | Updated November 2026, 6 hours ago
Venous thromboembolism (VTE) is a common disease that affects as many as 900,000 Americans yearly with an estimated 60,000 - 100,000 Americans dying each year as a result of VTE. D-Dimer levels indicates clotting cascade activation and fibrinolysis; it is the best assay to rule out VTE but it also comes with its challenges. The session will cover the clinical significance and guidelines of D-Dimer assays and factors that can affect interpretation of results.


Learning Objectives

- Review the Pathophysiology of D-Dimer and Clinical Indications for Testing.
- Discuss the available Laboratory Methods for D-Dimer Testing.
- Discuss the pre-analytic, analytic and post-analytic factors affecting D-Dimer assays.

Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety. CE credits are available for this webinar up to 1 year from the date of the live broadcast.

Speaker: Olajumoke O. Oladipo, MBBS, DABCC - Associate Professor of Pathology, Penn State Health Hershey Medical Center, Hershey, PA.
D Dimer: A routine assay with unique challengesIdentifying blood-based signatures of Traumatic Brain Injury using high sensitivity, multiplexed...Navigating Patient Testing Pitfalls: Lab Leaders Perspectives on Turning Practice Gaps into...Burn Fat, Not Muscle: Gene Silencing to Reprogram Fat, Boost Energy Expenditure, and Treat ObesityDigital pathology and Artificial Intelligence application in Hematological Diagnostics: Game...Revolutionizing Autoimmune Diagnostics: Dr. Veena Joy on CAR-T & Womens HealthKnow Thy Sample - 5 methods to quantify your protein and when to use themAnalysis of microplastics and other anthropogenic particles in different matricesMAFG A key regulator in melanoma progression and a potential therapeutic targetUsing algorithms and AI to make genomic data work better for patientsIntegrated quality control processes for cell therapy workflows using automated solutionsHbA1c Testing in Practice: Challenges and Opportunities in Point-of-Care and Laboratory Settings
Labroots |

D Dimer: A routine assay with unique challenges

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER